Place: IMTM, Olomouc
Date: June 17-18, 2024
PROGRAM Monday 17th June:
11:30-12:15 LUNCH
ROOM 1.09
12:15-12:30 INTRODUCTORY INFORMATION – Hajdúch
12:30-13:00 Hajdúch (DP 11) Biomarkers and molecular diagnostics for personalized medicine
13:00-13:30 Kudová (DP 6) - Study of functional and behavioral consequences of disease-associated mutations in the NMDA receptor and potential rescue pharmacology
13:30-14:00 Janeba (DP7) Purine nucleoside phosphorylase inhibitors for treatment of T-cell leukemia
14:00-14:15 BREAK
14:15-14:45 Tichý (DP 3) Novel nucleoside analogues as potent anticancer drugs
14:45-15:15 Maloy Řezáčová (DP4) – Theranostic applications of cancer specific carbonic anhydrases
15:15-15:45 Vrábel (DP 5) Development of chimeric antigen receptor modified immune cells for cancer immunotherapy
15:45-16:15 Nencka (DP 9) Novel (multi)targeted ligands of nuclear receptors for the therapy of the metabolic diseases
16:30-17:00 BOARD MEETING onsite and/or online (Decristoforo, Fusek, Hajdúch, Hauser, Martásek, Normanton, Perlík)
ROOM 2.48
12:30-14:00 and/or ADMINISTRATION MEETING (onsite and/or online)
14:15-15:45 Project managers of partners
18:00-20:00 DINNER (Konvikt Bistro&bar – Univerzitní 3, Olomouc)
-----------------------
PROGRAM Tuesday 18th June:
ROOM 1.09
09:00-9:30 Petřík (DP 10) - Targeted molecular imaging of infection and cancer disorders
9:30-10:00 Maletínská (DP 8) Interplay between anorexigenic and orexigenic peptides in Alzheimer’s-like pathology
10:00-10:30 Martásek (DP 13) - Biomedical prospecting of a life pigment: metabolic basis of inherited heme deficiency disorders
10:30-10:45 BREAK
10:45-11:15 Janovská (DP 12) – Casein kinase inhibitors for treatment of human cancers
11:15-11:45 Macek (DP 2) - Artificial intelligence, telemedicine and machine learning system for clinical applications
11:45-12:15 Brož (DP 1) - Development of informatic solutions enabling digitalization, interpretation and management of human genome data in clinical practice
12:15-13:00 LUNCH
National Centers of Competence
Personalised Medicine: From Translational Research into Biomedical Applications
PERMED: T2BA (TN02000109)
